In addition to the diminished ROS scavenging in the tumor microenvironment and the increased hypoxic environment leading to accelerated tumor progression, our data indicate that the tumor promotion in Cygb-deficient mice may also be attributed to an increased inflammatory environment, further supporting inflammation-associated cancer development. Here, CYGB is linked to cancer.